However, silencing LCN2 in tumor cells significantly attenuated these markers and reduced STAT3 phosphorylation in fibroblasts, indicating that LCN2 is a necessary paracrine effector downstream of EGFRvIII (Supplemental Fig. 8). This evidence concerns the gene LCN2 and neoplasm.